Sweet talk - insights into the nature & importance of glucose transport in lung epithelium

Abstract

For over 50 years glucose has been recognised to cross the lung epithelial barrier and be transported by lung epithelial cells. However until recently, research into these processes was focused on their effects on lung liquid volume. Here we consider a newly-identified role for pulmonary glucose transport in maintaining low airway surface liquid (ASL) glucose concentrations and propose that this contributes to lung defence against infection.

Glucose diffuses into ASL via paracellular pathways at a rate determined by paracellular permeability and the transepithelial glucose gradient. Glucose is removed from ASL in proximal airways via facilitative glucose transporters (GLUTs), down a concentration gradient generated by intracellular glucose metabolism. In distal lung, glucose transport via sodium-coupled glucose transporters (SGLTs) predominates. These processes vary between species but universally maintain ASL glucose at 3 to 20-fold lower concentrations than plasma.

ASL glucose concentrations are increased in respiratory disease and by hyperglycaemia. Elevated ASL glucose in intensive care patients was associated with increased Staphylococcus aureus infection. Diabetic patients with and without chronic lung disease are at increased risk of respiratory infection. Understanding of mechanisms underlying lung glucose homeostasis could identify new therapeutic targets for control of ASL glucose and prevention and treatment of lung infection.